Promising New Approach for a Fatal Neurological DisorderGUILFORD, Conn., Jan. 13, 2022 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage…
SAN DIEGO, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today Sorrento Therapeutics Mexico (“Sorrento…
Data confirm strong anticancer activity of two lead compounds in CT-01 programResults support advancement of CT-01 compounds towards IND expected…
-- DAYBREAK is the most comprehensive Phase 2 trial ever initiated in rare genetic diseases of obesity ---- DAYBREAK is…
– New commitment from the Bill & Melinda Gates Foundation supports the development of Vir’s novel “vaccinal antibody” technology as another…
Amendment and restatement of existing Master Facility License Agreement is to continue the establishment and operations of micro-clinics in Canada…
KITCHENER, ON / ACCESSWIRE / January 13, 2022 / Cloud DX Inc. ("Cloud DX" or the "Company") (TSXV:CDX) announces that…
Toronto, Ontario--(Newsfile Corp. - January 13, 2022) - Scryb Inc. (CSE: SCYB) (OTCQB: SCYRF) (FSE: EIY) ("Scryb'' or the "Company"), an applied…
LOMBARD, Ill, Jan. 13, 2022 /PRNewswire/ -- Forum Financial Management: What can RIAs learn from the healthcare industry about swift adaptation…
UTAH COUNTY, Utah, Jan. 13, 2022 /PRNewswire/ -- Premier Family Medical, a leading physician group in Utah County, announces additional services…